An Active Surveillance Study to Monitor the Safety of Abrocitinib Among Real-World Patients with Atopic Dermatitis (AD) in the European Union (EU) (B7451084)

30/10/2024
11/11/2025
EU PAS number:
EUPAS1000000282
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Updated protocol

B7451084_ABROCITINIB PROTOCOL AMENDMENT 1_23MAY2024.pdf

First published: 24/07/2024
English (1.6 MB - PDF) View document
Study results
Study report
Study report

B7451084_PROGESS REPORT 1_06OCT2025.pdf

English (274.72 KB - PDF) View document
Other information